Liraglutide has also been shown to possess potent anti-cancer properties:
The combined treatment of liraglutide and docetaxel (anti-cancer drug) worked synergistically in reducing the prostate cancer cells’ viability, causing cell cycle arrest, and inducing apoptosis (programmed cell death).
A review of studies showed that liraglutide treatment resulted in reduced multiplication of breast cancer cells